Explore the resources below to stay informed about
the latest approaches to type 2 diabetes and GLP-1 RA therapy.
The information contained in this site is intended for healthcare professionals only. This site is not intended to provide medical advice and/or treatment guidance. This site is not country-specific and therefore may contain information which is not applicable to your country. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site. By accessing this site and materials you accept this legal notice